Evaluation of metastatic meningioma with 2-deoxy-2-[18F]fluoro-D-glucose PET/CT

被引:17
|
作者
Ghodsian, M
Obrzut, SL
Hyde, CC
Watts, WJ
Schiepers, C
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Ahmanson Biol Imaging Ctr, Los Angeles, CA USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiat Oncol, Los Angeles, CA USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA USA
关键词
meningioma; FDG; PET/CT; positron emission; tomography; computed tomography;
D O I
10.1097/01.rlu.0000183612.63129.44
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: The purpose of this study was to characterize the 2-deoxy-2-[18F]fluoro-D-glucose (FDG) PET/CT imaging findings of sacral metastatic meningioma. Materials and Methods: An 18-year-old woman with a history of metastatic meningioma, who presented with intractable pain and spasm of the right lower extremity, underwent FDG PET/CT imaging. Results: FDG PET/CT scan demonstrated a moderately hypermetabolic sacral mass. The biopsy of the lesion was consistent with a high-grade malignant meningioma. Conclusions: Although meningioma is typically a benign tumor, in rare instances, it metastasizes. The current case example exhibits moderately increased metabolism despite findings of high-grade malignancy on biopsy.
引用
收藏
页码:717 / 720
页数:4
相关论文
共 50 条
  • [1] Autoradiolysis of the 2-deoxy-2-[18F]fluoro-D-glucose radiopharmaceutical
    E. Búriová
    F. Macášek
    F. Melichar
    M. Kropáček
    L. Procházka
    [J]. Journal of Radioanalytical and Nuclear Chemistry, 2005, 264 : 595 - 602
  • [2] Autoradiolysis of the 2-deoxy-2-[18F]fluoro-D-glucose radiopharmaceutical
    Búriová, E
    Macásek, F
    Melichar, F
    Kropácek, M
    Procházka, L
    [J]. JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, 2005, 264 (03) : 595 - 602
  • [3] Radiotherapeutic use of 2-deoxy-2-[18F]fluoro-D-glucose – a comment
    Michael Andrew Meyer
    [J]. Breast Cancer Research, 6
  • [4] Standardised uptake values of 2-deoxy-2-[18F]fluoro-D-glucose using PET/CT in normal cats
    Cho, Y. K.
    Lee, K. C.
    [J]. VETERINARNI MEDICINA, 2013, 58 (02) : 96 - 104
  • [5] In Vitro 2-Deoxy-2-[18F]Fluoro-D-Glucose Uptake: Practical Considerations
    Mertens, Koen
    Mees, Gilles
    Lambert, Bieke
    Van de Wiele, Christophe
    Goethals, Ingeborg
    [J]. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2012, 27 (03) : 183 - 188
  • [6] 2-deoxy-2-[18F]fluoro-D-glucose uptake and correlation to intratumoral heterogeneity
    Henriksson, Eva
    Kjellen, Elisabeth
    Wahlberg, Peter
    Ohlsson, Tomas
    Wennerberg, Johan
    Brun, Eva
    [J]. ANTICANCER RESEARCH, 2007, 27 (4B) : 2155 - 2159
  • [7] Integration of 2-deoxy-2-[18F] fluoro-d-glucose PET/CT into clinical management of patients with Wegener’s granulomatosis
    Ozlem Ozmen
    Ebru Tatci
    Atila Gokcek
    Deniz Koksal
    Yeliz Dadali
    Esra Ozaydin
    Nuri Arslan
    [J]. Annals of Nuclear Medicine, 2013, 27 : 907 - 915
  • [8] Fate of 2-deoxy-2-[18F]fluoro-D-glucose in control and diabetic rats
    Malaisse, WJ
    Damhaut, P
    Malaisse-Lagae, F
    Ladriere, L
    Olivares, E
    Goldman, S
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2000, 5 (05) : 525 - 532
  • [9] Integration of 2-deoxy-2-[18F] fluoro-d-glucose PET/CT into clinical management of patients with Wegener's granulomatosis
    Ozmen, Ozlem
    Tatci, Ebru
    Gokcek, Atila
    Koksal, Deniz
    Dadali, Yeliz
    Ozaydin, Esra
    Arslan, Nuri
    [J]. ANNALS OF NUCLEAR MEDICINE, 2013, 27 (10) : 907 - 915
  • [10] Metastatic prostate cancer: Initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose
    Shreve, PD
    Grossman, HB
    Gross, MD
    Wahl, RL
    [J]. RADIOLOGY, 1996, 199 (03) : 751 - 756